Benchmark Investment Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.06M Sell
2,032
-1,197
-37% -$612K 0.69% 40
2024
Q4
$1.63M Sell
3,229
-117
-3% -$66.5K 1.06% 25
2024
Q3
$1.96M Buy
3,346
+67
+2% +$37.9K 1.39% 23
2024
Q2
$1.67M Buy
3,279
+245
+8% +$120K 1.21% 21
2024
Q1
$1.5M Sell
3,034
-313
-9% -$159K 1.18% 25
2023
Q4
$1.76M Sell
3,347
-198
-6% -$106K 1.63% 20
2023
Q3
$1.79M Sell
3,545
-1,988
-36% -$978K 1.81% 17
2023
Q2
$2.66M Buy
5,533
+1,185
+27% +$579K 2.45% 6
2023
Q1
$2.05M Sell
4,348
-218
-5% -$105K 2.11% 12
2022
Q4
$2.42M Buy
4,566
+107
+2% +$56.7K 2.56% 5
2022
Q3
$2.25M Buy
4,459
+741
+20% +$390K 2.43% 7
2022
Q2
$1.91M Buy
3,718
+27
+0.7% +$13.6K 1.99% 14
2022
Q1
$1.88M Buy
3,691
+206
+6% +$99.4K 1.41% 20
2021
Q4
$1.75M Buy
+3,485
New +$1.58M 1.44% 22

Other funds holding UNH

Benchmark Investment Advisors's UNH Position: Q1 2025 in Review

Benchmark Investment Advisors reduced its UnitedHealth (UNH) stake by 37% in Q1 2025, selling an estimated $612K and leaving 2,032 shares worth $1.06M. The position accounts for 0.69% of the portfolio, ranked #40.

Benchmark Investment Advisors first reported a position in UNH in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.66M in Q2 2023. 3,603 funds tracked by Wall St. Rank hold UNH as of Q1 2025.

  • Benchmark Investment Advisors held 2,032 shares of UnitedHealth worth $1.06M as of Q1 2025.
  • Benchmark Investment Advisors sold 1,197 UnitedHealth shares in Q1 2025, an estimated $612K.
  • UnitedHealth made up 0.69% of Benchmark Investment Advisors's portfolio in Q1 2025, its #40 holding.
  • Benchmark Investment Advisors first reported a position in UnitedHealth in Q4 2021 and has held it in 14 quarters since.
  • Benchmark Investment Advisors's UnitedHealth position peaked at $2.66M in Q2 2023.
  • 3,603 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2025.

Based on Benchmark Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.